doi: 10.1002/jmv.1890220206.
Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS
- PMID: 3039052
- DOI: 10.1002/jmv.1890220206
Item in Clipboard
Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS
J Med Virol.
1987 Jun.
Abstract
Foscarnet was administered to eight AIDS patients for suspected cytomegalovirus (CMV) pneumonitis as a continuous intravenous infusion for a minimum of 8 days. All the patients improved, three showing complete resolution of symptoms. Evidence of CMV infection from bronchoalveolar lavage samples was lacking in two patients. Adverse drug experiences consisted of thrombophlebitis, transient decreases in haemoglobin concentration, and reversible rises in serum creatinine levels.
Similar articles
-
Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet).J Infect Dis. 1988 Mar;157(3):569-72. doi: 10.1093/infdis/157.3.569. J Infect Dis. 1988. PMID: 2830347 No abstract available.
-
Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.Antimicrob Agents Chemother. 1989 May;33(5):736-41. doi: 10.1128/AAC.33.5.736. Antimicrob Agents Chemother. 1989. PMID: 2546490 Free PMC article.
-
Foscarnet for cytomegalovirus pneumonitis.Lancet. 1985 May 18;1(8438):1151. doi: 10.1016/s0140-6736(85)92447-x. Lancet. 1985. PMID: 2860348 No abstract available.
-
[Treatment of cytomegalovirus infections in immunosuppressed patients].Ann Med Interne (Paris). 1988;139(7):511-5. Ann Med Interne (Paris). 1988. PMID: 2854380 Review. French. No abstract available.
-
Cytomegalovirus infection in the acquired immune deficiency syndrome.J Antimicrob Chemother. 1989 Jun;23 Suppl E:31-6. doi: 10.1093/jac/23.suppl_e.31. J Antimicrob Chemother. 1989. PMID: 2550410 Review.
Cited by
-
Acquisition of cytomegalovirus infection: an update.Clin Microbiol Rev. 1989 Apr;2(2):204-16. doi: 10.1128/CMR.2.2.204. Clin Microbiol Rev. 1989. PMID: 2539899 Free PMC article. Review.
-
Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis.Antimicrob Agents Chemother. 1989 May;33(5):742-5. doi: 10.1128/AAC.33.5.742. Antimicrob Agents Chemother. 1989. PMID: 2546491 Free PMC article.
-
Age-related differences in phosphonoformate-induced bone toxicity in cats.Calcif Tissue Int. 1991 May;48(5):353-61. doi: 10.1007/BF02556155. Calcif Tissue Int. 1991. PMID: 1829019
-
Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.Drugs. 1994 Aug;48(2):199-226. doi: 10.2165/00003495-199448020-00007. Drugs. 1994. PMID: 7527325 Review.
-
Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.Drugs. 1991 Jan;41(1):104-29. doi: 10.2165/00003495-199141010-00009. Drugs. 1991. PMID: 1706982 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
